Why the study?
Does monophosphoryl lipid A improve regional segment shortening in a canine model of myocardial stunning?
Does monophosphoryl lipid A improve regional segment shortening in a canine model of myocardial stunning?
Monophosphoryl lipid A attenuates myocardial stunning in a canine model via an ATP-sensitive potassium channel-dependent mechanism, mimicking the second window of ischemic preconditioning.
No takes yet. Share an insight, caveat, or question.
Supports K-ATP channel mediation of delayed preconditioning in canines; leaves open clinical translation to human myocardial stunning.
Elliott et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: